Skip to main content
Skip to content
Case File
efta-01519445DOJ Data Set 10Other

EFTA01519445

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01519445
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CH ISLA IN E MAXWELL - OAP IHD ACCT For the Period 2/1/14 to 2/28/14 Equity Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation EAFE Equity 1.847.938.92 137,528.10 Market Value/Cost Current Period Value Market Value Tax Cost Unrealized Gain/Loss Estimated Annual Income Accrued Dividends 12,568.34 Yield 3.71% 137,528.10 132,686.12 4,841.98 5.106.04 Equity Detail (1.710 410 82) 100% Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield EAFE Equity ASTRAZENECA PLC 67.76 0.00 4.13% SPONS ADR 624.15 046353-10-8 AZN GLAXOSMITHKLINE PLC 55.94 0.00 4 41", SPONS ADR 684.77 37733W.10-5 GSK J.P.Morgan Account Page 4 of 15 Consolidated Statement Page 38 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPN1-SDNY-00046731 SDNY_GM_00315929 EFTA01519445

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.